Platitudes about 'Product Stewardship' in Torts: Continuing Drug Research and Education

36 Pages Posted: 15 Dec 2008  

Lars Noah

University of Florida - Levin College of Law

Date Written: December 15, 2008

Abstract

This paper focuses on one emerging aspect of tort litigation against pharmaceutical manufacturers that, if it gained traction, portends a dramatic (and potentially counterproductive) expansion in the prescription drug industry's exposure to liability. A growing chorus of commentators would impose on pharmaceutical manufacturers a broader duty to test and educate (aspects of what they call an obligation of "product stewardship" or "informed choice"). This paper explains the serious flaws in such proposals, but it also suggests one novel basis for imposing liability (distribution restrictions) that might make some sense. Genuine product stewardship, at least if understood as an effort to make the most of a scarce resource, strikes me as far more defensible than the approaches suggested by other commentators.

Suggested Citation

Noah, Lars, Platitudes about 'Product Stewardship' in Torts: Continuing Drug Research and Education (December 15, 2008). Michigan Telecommunications and Technology Law Review, Vol. 15, 2009. Available at SSRN: https://ssrn.com/abstract=1316373

Lars Noah (Contact Author)

University of Florida - Levin College of Law ( email )

P.O. Box 117625
Gainesville, FL 32611-7625
United States
352-273-0923 (Phone)
352-392-3005 (Fax)

HOME PAGE: http://www.law.ufl.edu/faculty/lars-noah

Paper statistics

Downloads
63
Rank
290,411
Abstract Views
711